See more : LifeStance Health Group, Inc. (LFST) Income Statement Analysis – Financial Results
Complete financial analysis of Sotera Health Company (SHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sotera Health Company, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Nokia Oyj (NOA3.DE) Income Statement Analysis – Financial Results
- Manulife Financial Corp (MNQFF) Income Statement Analysis – Financial Results
- QUEST CAPITAL MARKETS LIMITED (QUESTCAP.BO) Income Statement Analysis – Financial Results
- Storage Drop Storage Technologies Ltd (STRG.TA) Income Statement Analysis – Financial Results
- Top Ships Inc. (TOPS) Income Statement Analysis – Financial Results
Sotera Health Company (SHC)
About Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.05B | 1.00B | 931.48M | 818.16M | 778.33M | 746.15M |
| Cost of Revenue | 472.13M | 446.68M | 412.81M | 374.59M | 382.90M | 388.90M |
| Gross Profit | 577.16M | 557.00M | 518.67M | 443.57M | 395.43M | 357.25M |
| Gross Profit Ratio | 55.00% | 55.50% | 55.68% | 54.22% | 50.81% | 47.88% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 133.36M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 236.67M | 245.71M | 198.16M | 178.53M | 147.48M | 133.36M |
| Other Expenses | 63.80M | 62.94M | 63.78M | 59.03M | 58.56M | 3.87M |
| Operating Expenses | 300.47M | 308.65M | 261.94M | 237.55M | 206.04M | 191.34M |
| Cost & Expenses | 772.60M | 755.34M | 674.75M | 612.14M | 588.94M | 580.24M |
| Interest Income | 0.00 | 80.14M | 74.19M | 215.26M | 157.73M | 0.00 |
| Interest Expense | 142.88M | 80.14M | 74.19M | 215.26M | 157.73M | 143.33M |
| Depreciation & Amortization | 160.34M | 147.75M | 153.15M | 145.51M | 148.77M | 148.15M |
| EBITDA | 420.20M | -2.99M | 404.25M | 319.96M | 305.25M | 316.60M |
| EBITDA Ratio | 40.05% | 31.66% | 36.04% | 33.55% | 44.11% | 42.43% |
| Operating Income | 276.69M | 248.35M | 256.73M | 206.02M | 183.60M | 80.85M |
| Operating Income Ratio | 26.37% | 24.74% | 27.56% | 25.18% | 23.59% | 10.84% |
| Total Other Income/Expenses | -170.67M | -491.46M | -81.02M | -244.88M | -184.51M | -56.63M |
| Income Before Tax | 106.03M | -243.11M | 175.72M | -38.86M | -916.00K | 24.22M |
| Income Before Tax Ratio | 10.10% | -24.22% | 18.86% | -4.75% | -0.12% | 3.25% |
| Income Tax Expense | 54.65M | -9.54M | 58.60M | -1.37M | 19.51M | 30.10M |
| Net Income | 51.38M | -233.57M | 116.88M | -37.49M | -20.43M | -5.87M |
| Net Income Ratio | 4.90% | -23.27% | 12.55% | -4.58% | -2.62% | -0.79% |
| EPS | 0.18 | -0.83 | 0.41 | -0.13 | -0.07 | -0.02 |
| EPS Diluted | 0.18 | -0.83 | 0.41 | -0.13 | -0.07 | -0.02 |
| Weighted Avg Shares Out | 281.01M | 280.10M | 279.23M | 283.25M | 284.42M | 246.15M |
| Weighted Avg Shares Out (Dil) | 283.22M | 280.10M | 279.38M | 283.25M | 284.42M | 246.15M |
Sotera Health Company (SHC) Meets Q4 Earnings Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.26 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.25 per share a year ago.
Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook
CLEVELAND, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for...
Unveiling Sotera Health Company (SHC) Q4 Outlook: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Sotera Health Company (SHC) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Sotera Health Company (SHC) Earnings Expected to Grow: Should You Buy?
Sotera Health Company (SHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sotera Health Announces Fourth-Quarter and Full-Year 2023 Earnings Release Date
CLEVELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results...
Sotera Health Chairman and CEO Presents at 42nd Annual J.P. Morgan Healthcare Conference
CLEVELAND, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, is presenting today at...
Sotera Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CLEVELAND, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and...
3 Niche Tech Stocks With Untapped Potential
What comes to mind when you think of niche stock? For some, it is one that flies under the radar of most investors.
Sotera Health Appoints Karen Flynn to Board of Directors
CLEVELAND, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced today it has appointed Karen Flynn as a new independent...
Sotera Health Company (SHC) Q3 2023 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q3 2023 Earnings Conference Call November 1, 2023 9:00 AM ET Corporate Participants Jason Peterson - Vice President and Treasurer Michael Petras - Chairman and Chief Executive Officer Jonathan Lyons - Senior Vice President and...
Source: https://incomestatements.info
Category: Stock Reports